Furthermore, Kayama et al. reported that CX3CR1+ intestinal macrophages were able to produce high concentrations of IL-1β and IL-6 via activation of TLR4, and that suppression of this pathway resulted in the amelioration of DSS-induced colitis (46). The gene discussed is TLR4; the disease is colitis.